Sabra Health Care REIT Reports Officer/Director Changes, Comp Arrangements

TL;DR

**Sabra Health Care REIT just filed an 8-K about executive changes and pay, keep an eye out for details.**

AI Summary

Sabra Health Care REIT, Inc. filed an 8-K on January 4, 2024, reporting an event that occurred on December 29, 2023. This filing indicates changes related to the departure or election of directors, appointment of officers, and compensatory arrangements for certain officers. While specific names or dollar amounts are not detailed in this summary, the filing signals potential shifts in leadership or executive compensation, which could impact the company's strategic direction and financial performance. Investors should monitor subsequent disclosures for details on these changes, as they could influence future stock performance.

Why It Matters

Changes in executive leadership or compensation can signal strategic shifts or financial health, directly impacting investor confidence and the company's future trajectory.

Risk Assessment

Risk Level: medium — The filing indicates changes in leadership and compensation, which can introduce uncertainty regarding future company strategy and performance until specific details are disclosed.

Analyst Insight

A smart investor would monitor Sabra Health Care REIT, Inc.'s subsequent filings and press releases for specific names, roles, and financial details related to the reported officer and director changes and compensatory arrangements, as these specifics will determine the true impact on the company's outlook.

Key Players & Entities

• Sabra Health Care REIT, Inc. (company) — the registrant filing the 8-K
• December 29, 2023 (date) — date of earliest event reported
• January 4, 2024 (date) — date the 8-K was filed
• 001-34950 (other) — Commission File Number for Sabra Health Care REIT, Inc.
• SBRA (other) — trading symbol for Sabra Health Care REIT, Inc. common stock

Forward-Looking Statements

• Sabra Health Care REIT, Inc. will release further details regarding the specific personnel changes and compensation arrangements mentioned in this 8-K. (Sabra Health Care REIT, Inc.) — high confidence, target: Q1 2024
• The market will react to the specific details of the executive changes and compensation, potentially causing short-term stock volatility. (SBRA stock price) — medium confidence, target: Within 1 month of detailed disclosure

FAQ

From the Filing

0001492298-24-000003.txt : 20240104 0001492298-24-000003.hdr.sgml : 20240104 20240104091524 ACCESSION NUMBER: 0001492298-24-000003 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20231229 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240104 DATE AS OF CHANGE: 20240104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sabra Health Care REIT, Inc. CENTRAL INDEX KEY: 0001492298 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 272560479 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34950 FILM NUMBER: 24509920 BUSINESS ADDRESS: STREET 1: 18500 VON KARMAN STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 888-393-8248 MAIL ADDRESS: STREET 1: 18500 VON KARMAN STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 8-K 1 sbra-20231229.htm 8-K sbra-20231229 false 0001492298 0001492298 2023-12-29 2023-12-29     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):  December 29, 2023 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter)   Maryland   001-34950   27-2560479 (State of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   18500 Von Karman Avenue Suite 550 Irvine CA 92612 (Address of principal executive offices) (Zip Code) Registrant's telephone number including area code: ( 888 )  393-8248   (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol(s) Name of each exchange on which registered Common stock, $0.01 par value SBRA The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Executive Officer On and effective as of January 1, 2024, the Board of Directors of Sabra Health Care REIT, Inc., a Maryland corporation (“Sabra” or the “Company”), appointed Jessica Flores to serve as Executive Vice President and Chief Accounting Officer until her successor is duly elected and qualifies. In this position, Ms. Flores will replace and succeed Michael Costa as the Company’s Principal Accounting Officer. Mr. Costa will continue to serve as the Compan